Unravelling the enhanced vaccine immunity by heterologous KCONVAC/Ad5-nCoV COVID-19 vaccination

Signal Transduct Target Ther. 2022 Jul 4;7(1):210. doi: 10.1038/s41392-022-01079-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines / therapeutic use
  • COVID-19* / prevention & control
  • Humans
  • Vaccination
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines